Advertisement
Canada markets closed

  • S&P/TSX

    21,947.41
    +124.19 (+0.57%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • DOW

    38,675.68
    +450.02 (+1.18%)
     

  • CAD/USD

    0.7308
    -0.0006 (-0.08%)
     

  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     

  • Bitcoin CAD

    86,622.53
    +390.00 (+0.45%)
     

  • CMC Crypto 200

    1,316.51
    +39.53 (+3.10%)
     

  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     

  • RUSSELL 2000

    2,035.72
    +19.61 (+0.97%)
     

  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     

  • NASDAQ

    16,156.33
    +315.37 (+1.99%)
     

  • VOLATILITY

    13.49
    -1.19 (-8.11%)
     

  • FTSE

    8,213.49
    +41.34 (+0.51%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • CAD/EUR

    0.6787
    -0.0030 (-0.44%)
     

Exclusive Insight on FITX, TTNP and NTEK

ACCESSWIRE

Creative Edge Nutrition, Inc. (OTC:FITX - News), Titan Pharmaceuticals Inc. (OTC:TTNP - News) and NanoTech Entertainment, Inc. (OTC:NTEK - News) have been added to our watch list.

Creative Edge Nutrition, Inc. (OTC:FITX - News) is a nutritional supplement company, It develops, markets, and sells nutraceuticals and health supplements. The company offers a range of capsules, tablets and powders. It’s products comprise HYPER INFUSION, CENTRO PLEX, ALPHA DRIVE, INOVA and THYROZINE. The company also provides natural products, such as Hemp Nutra tea and slimming tea.

On November 13th, FITX announced that it retained 5W Public Relations as their agency of record. 5W Public Relations is one of the 25 largest independently owned PR firms in the US. The company will execute a comprehensive public relations program designed to increase awareness of Creative Edge Nutrition.

For our complete article on FITX please go here: http://tinyurl.com/OTCmagic-FITX

Titan Pharmaceuticals Inc. (OTC:TTNP - News) is a biopharmaceutical company. It engages in developing proprietary therapeutics for the treatment of serious medical disorders in the U.S. It offers Fanapt (iloperidone) for the treatment of schizophrenia. The company is involved in developing Probuphine for the treatment of opioid dependence.

On November 13th, TTNP announced a $5 million equity investment by Braeburn Pharmaceuticals Sprl and a restructuring of certain terms of the License Agreement for commercialization of Probuphine®. The agreement shows that Titan's need to address its cash flow requirements through next year.

For our complete article on TTNP please go here: http://tinyurl.com/OTCmagic-TTNP

NanoTech Entertainment, Inc. (OTC:NTEK - News) engages in the provision of consulting services and installation for residential and commercial buildings. It offers consulting services, including site audits and accessibility planning and development. It was previously known as Finishing Touches Home Goods, Inc and changed its name to Endeavor IP Inc recently.

On Novenber 13th, it announced the addition of Aaron Hightower to its executive team. Mr. Hightower will head the Las Vegas Gaming operations, specifically in the realm of ‘repeat gameplay’ design. Previously, he worked as a lead engineer at IGT.

For our complete article on NTEK please go here: http://tinyurl.com/OTCmagic-NTEK

OTCMAGIC is a newsletter that reports on developments in the world of penny stocks. OTCMagic is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit OTCMagic.com website, for complete risks and disclosures.

Subscribe Here: http://www.otcmagic.com/

Contact Info:
OTCMagic
info@otcmagic.com